Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

FDA approves Gadavist for patients younger than 2

The FDA has approved Bayer’s Gadavist (gadobutrol) injection as the first MRI contrast agent for pediatric patients younger than two years of age, including term neonates.

Thumbnail

How lung metastases travel through airways and what it means for treatment

Lung cancer, particularly adenocarcinoma, may spread through the airway, according to a review article published in the December 2014 issue of the American Journal of Roentgenology. These intrapulmonary aerogenous metastases will have implications for staging, management and prognosis.

PET study highlights differences in smoking response between men and women

Researchers at Yale have confirmed that smoking cigarettes activates the brain’s pleasure and satisfaction response differently in men compared with women, a discovery that could help aid addiction treatment.

NHS pushes for major multi-site genomics project

The United Kingdom’s National Health Service (NHS) is embarking on an ambitious gene-sequencing project with 11 genomics institutions in England. The objective is to find targeted treatments for a spectrum of illnesses.

Thumbnail

Zecotek settles patent suit against Philips, Saint Gobain

Singapore-based Zecotek Photonics, makers of industrial imaging technologies, announced today that the company has settled a lawsuit brought against Philips and Saint Gobain over patent infringement regarding new PET detector technology.

Quantitative FET-PET makes the grade for advanced glioma

High-grade astrocytoma is a particularly aggressive form of glioma. Parameters of PET imaging such as the minimal time-to-peak could help clinicians narrow in on the best line of treatment for each patient, according to a study published Dec. 23 in the Journal of Nuclear Medicine.

Hedge fund CEO gifts $15M for Alzheimer’s institute

The chief executive officer of Park Avenue hedge fund Third Point, is set to donate $15 million to Mount Sinai Hospital and the Icahn School of Medicine in New York City for a new research institute devoted to studying Alzheimer’s disease.

Thumbnail

Big brain gene could inform treatments for neurodevelopmental disorders

One gene in particular could be the key master for proper brain development, researchers from the Agency for Science, Technology and Researc

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.